Joan is a Research Scientist and part-time Instructor in the Biotechnology Program at BCIT, where students earn a joint BCIT-UBC Bachelor Honours Degree in Biotechnology. She has taught core courses in molecular genetics, introduction to biotechnology and currently teaches protein biochemistry and advanced animal cell biology. Joan has almost 20 years of post-doctoral work experience and has conducted research in both the academic and biotechnology sectors. She has consequently developed a diverse background in several areas of molecular and cell biology, with a particular interest in the molecular biology of stem cells.
Industry Experience: Prior to joining at BCIT, Joan worked for over five years at Chromos Molecular Systems as a Sr. Scientist and Team Leader for their Cell Line Engineering program. She led all projects focused on enhancing gene targeting and expression, and was successful in engineering Chromos' proprietary (US Patents 20050181506 & 0120064578) ACE System vectors (Perkins et.al.). Joan was also responsible for engineering a manufacturing (CHO) cell line for a first-in-class therapeutic monoclonal antibody, which is now undergoing clinical development by Glenmark and Sanofi Pharma for the treatment of multiple sclerosis and Crohn's disease, respectively (Bloomberg; Nature Biotech).
Academic Background: Joan's Ph.D thesis focused on the biochemical purification and characterization of a novel & selective growth regulator of hematopoietic progenitor cells (Shellard et.al.; Logan, Shellard et.al.). This regulator belongs to a class of neutrophilic granule proteins that mediate a variety of pro-inflammatory activities and Joan is credited as the first researcher to identify its regulatory role in hematopoiesis and the pathogenesis of myeloid leukemias (Ouriaghli et.al.; Tavor et.al.). Joan's post-doctoral work expanded her expertise in the molecular mechanisms governing embryonic and stem cell development. In the Zoology department at UBC, she analyzed the Polycomb gene, Asx, in fruit fly development (Sinclair et.al.) and at the Institut Pasteur (Paris, France), she studied the role of Leukemia Inhibitory Factor (LIF) in maintaining the totipotency of mouse embryonic stem cells (Shellard et.al.).
SW09 208 - Burnaby Campus
Ph.D., EIT, Instructor, Program Coordinator, Civil Engineering, School of Construction and the Environment
University of British Columbia, Ph.D., 2014
B.A. Chemistry cum laude, 1989. Minor in Classical Studies. University of Puget Sound.
Mastercard Chair in Digital Trust, Faculty, School of Computing
Director, Natural Health and Food Products Research Group (NRG), Canada Research Chair in Phytoanalytics
Associate Dean, Building Design and Construction Technology, Director, Sustainable Development and Environmental Stewardship.
Rodrigo Mora, PhD, P.Eng.
Industry and academic veteran with extensive interdisciplinary research and HQP training experience in Smart Grid, Electric Utility Systems and Energy Management System (EMS) research in North America and Asia. Internationally recognized researcher and leader for his contributions to Smart Grid research and project/services developments with numerous publications and HQP training in various areas related to Smart Grid. Principal Investigator and Scientific Director of two joint government/industry funded Pan Canadian Strategic Research networks, involving Canadian Universities, Government Institutes, Electric Utilities and Private Sector in Interdisciplinary Research into Smart Grid and Cyber Security (please, see links below):